Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Further evidence that ribavirin interacts with eIF4E.

Alex Kentsis1, Laurent Volpon, Ivan Topisirovic

  • 1Mount Sinai School of Medicine, New York University, New York, NY 10029, USA.

RNA (New York, N.Y.)
|October 28, 2005
PubMed
Summary

Ribavirin may not bind to eukaryotic initiation factor 4E (eIF4E), challenging its role in inhibiting mRNA translation. Mass spectrometry confirms ribavirin specifically binds to eIF4E, supporting its antiviral mechanism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity.

Molecular and cellular biology·2026
Same author

Elongationless start-stop elements are stress-resilient translation gates that are more repressive than uTranslons.

Nucleic acids research·2026
Same author

Co-option of lineage plasticity as a hallmark of multipotent acute leukemias.

Blood neoplasia·2026
Same author

Escorting mRNAs - the multifunctional and divergent roles of cap-chaperones in post-transcriptional gene expression.

Journal of cell science·2026
Same author

eIF4E and Ezrin cooperate in pseudopods to drive a localized migratory translation program in acute myeloid leukemia.

bioRxiv : the preprint server for biology·2026
Same author

Mitochondrial ETF insufficiency drives neoplastic growth by selectively optimizing cancer bioenergetics.

eLife·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • Recent studies reported ribavirin's inability to bind eukaryotic initiation factor 4E (eIF4E) and inhibit cap-dependent mRNA translation in vitro.
  • This challenges the established understanding of ribavirin's mechanism of action as an antiviral agent.

Discussion:

  • The commentary examines discrepancies in findings regarding ribavirin-eIF4E binding using techniques like affinity chromatography and fluorescence spectroscopy.
  • Limitations of using cell extracts for studying mRNA translation mechanisms are discussed.
  • Potential explanations for conflicting results between different research groups are explored.

Key Insights:

  • Direct mass spectrometry analysis provides evidence for the specific binding of ribavirin to eIF4E.

Related Experiment Videos

  • This finding supports the hypothesis that ribavirin inhibits viral replication by interfering with host translation machinery.

    • Outlook:

    • Further research is needed to fully elucidate the precise molecular interactions between ribavirin and eIF4E.
    • Understanding these interactions could lead to the development of more effective antiviral therapies.
    • Investigating the role of eIF4E in other viral infections is warranted.